Neogen
NEOG
$12.14
Share price
1.51%
Change (1 day)
-27.82%
Change (1 year)
Neogen (NEOG) - Cash on Hand
Cash on Hand as of November 2023 : $0.23 B
According to Neogen's latest financial reports the company has $0.23 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Neogen - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-05-31 | $0.24 B | -35.55% |
| 2022-05-31 | $0.38 B | -0.01% |
| 2021-05-31 | $0.38 B | 10.89% |
| 2020-05-31 | $0.34 B | 28.46% |
| 2019-05-31 | $0.26 B | 26.9% |
| 2018-05-31 | $0.21 B | 46.77% |
| 2017-05-31 | $0.14 B | 33.25% |
| 2016-05-31 | $0.10 B | -5.58% |
| 2015-05-31 | $0.11 B | 49.24% |
| 2014-05-31 | $76.49 M | -10.39% |
| 2013-05-31 | $85.36 M | 24.36% |
| 2012-05-31 | $68.64 M | 22.4% |
| 2011-05-31 | $56.08 M | 145.91% |
| 2010-05-31 | $22.8 M | 64.76% |
| 2009-05-31 | $13.84 M | -3% |
| 2008-05-31 | $14.27 M | 6.3% |
| 2007-05-31 | $13.42 M | 585.25% |
| 2006-05-31 | $1.95 M | -0.66% |
| 2005-05-31 | $1.97 M | 16.27% |
| 2004-05-31 | $1.69 M | -80.94% |
| 2003-05-31 | $8.89 M | 40.04% |
| 2002-05-31 | $6.35 M | -11.54% |
| 2001-05-31 | $7.18 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $8.07 B | 3,407.68% | 🇺🇸 USA |
 Becton Dickinson BDX | $1.18 B | 413.32% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | $0.45 B | 97.13% | 🇺🇸 USA |
 Illumina ILMN | $1.05 B | 357.73% | 🇺🇸 USA |
 Danaher DHR | $5.86 B | 2,446.62% | 🇺🇸 USA |
 PerkinElmer
PKI | $2.46 B | 968.83% | 🇺🇸 USA |
 Pacific Biosciences
PACB | $0.63 B | 174.21% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $81.45 M | -64.63% | 🇺🇸 USA |